Makale detayı · 2011
Strategies to manage retinoblastoma in developing countries
Dergi
Pediatric Blood & CancerISSN 1545-5009
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
- Yıl
- 2011
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı Pediatric Blood & Cancer
- Katalog eşleşmesi (ISSN) Pediatric Blood and Cancer
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
OpenAlex · İngilizce
Survival of retinoblastoma is >90% in developed countries but there are significant differences with developing countries in stage at presentation, available treatment options, family compliance, and survival. In low-income countries (LICs), children present with advanced disease, and the reasons are socioeconomic and cultural. In middle-income countries (MICs), survival rates are better (>70%), but there is a high prevalence of microscopically disseminated extraocular disease. Programs for eye preservation have been developed, but toxicity-related mortality is higher. Although effective treatment of microscopically extraocular disease improved the outcome, worldwide survival will be increased only by earlier diagnosis and better treatment adherence.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
166 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Challenges and differences in external radiation therapy for retinoblastoma from standard techniques to new developments 2015
- Chemotherapy in Retinoblastoma: Current Approaches 2015
- Retinoblastomda Kemoterapi: Güncel Yaklaşımlar (Chemotherapy in Retinoblastoma: Current Approaches) 2015
- Chemotherapy in Retinoblastoma Current Approaches 2015
- A 20-year audit of retinoblastoma treatment outcomes 2020
- Intraocular retinoblastoma features and treatment outcomes according to patient age at initial presentation 2026
- Surgical treatment of huge orbital retinoblastoma under general anesthesia in a three-year old child 2022